MEDVi Oral Semaglutide Cost: Is the $70 Tablet Upgrade Worth It?

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

MEDVi's oral semaglutide tablet adds exactly $70 to the monthly injection price—at both the introductory stage and every refill. That ongoing surcharge totals $840 over 12 months. MEDVi's semaglutide injection refills at $299/month; the oral tablet refills at $369/month (after a $249 first month). PlexusDx oral semaglutide is $289/month with no introductory discount and no contract—$80/month less than MEDVi's oral option at refill, and $10/month less than MEDVi's injectable. Whether the upgrade is "worth it" depends on whether you value oral delivery strongly enough to pay $80/month more than a competing oral option, or $70/month more than MEDVi's own injection.

At-a-glance: MEDVi oral vs injection vs PlexusDx oral

Breaking down the $70 tablet surcharge

MEDVi's oral semaglutide tablet is priced as a $70 monthly add-on to the injectable base, applied at both the introductory and refill stages. The first month costs $249 (calculated as $179 injection introductory rate + $70 tablet surcharge). Each refill costs $369 (calculated as $299 injection refill + $70 tablet surcharge). The surcharge is ongoing—not a one-time setup fee. Over 12 months the tablet route costs $4,308 versus $3,468 for MEDVi's injection, a difference of $840 or $70/month average. (Our calculation, verified September 4, 2026.)

MEDVi's pricing structure is transparent: the website clearly states the tablet surcharge, and our checkout verification confirmed the figures at each stage. Supply is 4 weeks per shipment for both routes. Dose increases do not raise the monthly price.

Like-for-like comparison: MEDVi oral vs PlexusDx oral

PlexusDx oral semaglutide is $289/month on a month-to-month basis, with no introductory discount and no refill jump. Over 12 months that totals $3,468 (our calculation). MEDVi's oral tablet totals $4,308 over the same period—$840 more, or $80/month more than PlexusDx oral at the refill stage. PlexusDx also offers 3-month ($269/month) and 6-month ($249/month) commitment tiers; the 6-month rate brings the 12-month total to $2,988, widening the gap to $1,320 versus MEDVi's oral.

Notably, PlexusDx oral semaglutide costs $10/month less than MEDVi's injectable option at refill ($289 vs $299), and $1,200 less over 12 months than MEDVi's injection ($3,468 vs $3,468 month-to-month—the totals match because MEDVi's first-month discount offsets PlexusDx's flat rate exactly).

What the oral tablet surcharge buys—and doesn't

MEDVi's $70 surcharge covers the formulation and packaging of the oral tablet; it does not unlock additional clinical services or change the consultation, support, or shipping model. Both MEDVi's injection and oral tablet include medication, clinician consult, unlimited support access, and shipping at the quoted monthly price. The oral route avoids subcutaneous injection but requires daily dosing (versus weekly for injection), and compounded oral semaglutide absorption may vary more than injection. Neither MEDVi nor PlexusDx publishes head-to-head efficacy data for compounded oral versus injectable semaglutide; individual response varies and a licensed provider determines which route is appropriate.

MEDVi's oral surcharge applies to semaglutide; our checkout verification (September 4, 2026) found no separate oral surcharge displayed for tirzepatide, though both injection and oral routes are advertised at the same $279 first-month / $399 refill rate for tirzepatide.

Service quality and support: review evidence

MEDVi holds a 4.3-star rating on Trustpilot with approximately 15,000 reviews (captured September 4, 2026). Positive themes center on responsive customer service, ease of onboarding, and the included unlimited clinician support. Negative themes on Trustpilot and Reddit include reports of delayed prescription fulfillment during 2024–2025 shortages, occasional difficulty reaching support during high-volume periods, and billing clarity around the branded-drug pathway membership. These are individual reports and allegations; experiences vary and many reviewers report smooth service.

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). PlexusDx includes a free check-in with a Doctor of Pharmacy and works with licensed 503A compounding pharmacies.

Both programs require a licensed provider to determine eligibility and appropriateness; neither guarantees medication, dose, or results.

Choose MEDVi oral semaglutide if…

• You strongly prefer oral delivery over injection and are willing to pay $369/month ongoing ($249 first month) for that convenience.
• You value unlimited clinician support access and MEDVi's integrated coaching and dietitian services as part of the monthly price.
• The $70/month surcharge over MEDVi's own injection—or $80/month over PlexusDx oral—fits your budget and priorities.
• You have reviewed MEDVi's 4.3-star Trustpilot profile and are comfortable with the reported service trade-offs during high-demand periods.

Choose PlexusDx oral semaglutide if…

• You want oral semaglutide at $289/month with no introductory discount and no refill jump—$80/month less than MEDVi's oral tablet at refill.
• You prefer a flat-rate structure with optional 3-month ($269/month) or 6-month ($249/month) commitment discounts.
• You value a free Doctor of Pharmacy check-in and transparent 503A compounding pharmacy partnerships.
• You want to avoid the $70 tablet surcharge and pay less per month than MEDVi's injectable option.

Methodology and freshness

MEDVi pricing was verified via completed checkout intake on September 4, 2026, stopping at the results/selection page before payment. Screenshots and URL captures are on file. The $70 oral tablet surcharge was confirmed at both introductory and refill stages. PlexusDx pricing was captured July 20, 2026, and cross-verified against standing pricing rules. All 12-month cost totals are our calculation, summing first-month and refill rates without discounting for multi-month commitments unless explicitly stated. Trustpilot ratings and review counts were captured September 4, 2026. Neither provider guarantees eligibility, medication, dose, or clinical outcomes; a licensed provider determines fit in every case.

Frequently Asked Questions

Does MEDVi's $70 tablet surcharge apply every month?

Yes. MEDVi's oral semaglutide tablet adds $70 to the injection price at both the first month and every refill. Over 12 months that surcharge totals $840. The surcharge is not a one-time setup fee; it is an ongoing monthly add-on for the oral route.

Is oral semaglutide as effective as the injection?

Neither MEDVi nor PlexusDx publishes head-to-head efficacy data for compounded oral versus injectable semaglutide. Oral absorption may vary more than subcutaneous injection, and individual response differs. A licensed provider determines which route is appropriate for each patient; neither route guarantees weight-loss results.

Can I switch from MEDVi oral to PlexusDx oral mid-treatment?

Switching providers mid-treatment requires a new intake and provider evaluation. Neither MEDVi nor PlexusDx guarantees uninterrupted transfers or the same dose continuation. Dose and medication decisions are made by the receiving provider based on clinical appropriateness, not patient preference alone.

Does PlexusDx oral semaglutide have an introductory discount?

No. PlexusDx oral semaglutide is $289/month on a month-to-month basis with no first-month discount and no refill jump. Commitment tiers (3-month at $269/month, 6-month at $249/month) lower the per-month rate in exchange for upfront payment or a recurring commitment, but there is no separate "first month" promotional rate.

Why does MEDVi charge more for the oral tablet?

MEDVi's $70 surcharge reflects the formulation and packaging cost of the oral tablet versus the injectable. The surcharge does not add clinical services, support access, or shipping; those are included in both routes. Oral compounded semaglutide requires daily dosing and may have different absorption characteristics than weekly injection.

Sources

• PlexusDx, Weight Management Protocols, accessed July 20, 2026 and September 4, 2026.
• MEDVi, https://glp1.medvi.org/, checkout verification completed September 4, 2026.
• Trustpilot, MEDVi profile, accessed September 4, 2026.
• Trustpilot, PlexusDx profile, accessed September 4, 2026.
• Reddit, r/Semaglutide and r/GLP1, threads mentioning MEDVi service experience, accessed September 4, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.